SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-031536
Filing Date
2023-09-01
Accepted
2023-09-01 18:00:32
Documents
1
Period of Report
2023-08-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4020
  Complete submission text file 0001493152-23-031536.txt   5539
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 543 LOMBARD ST SAN FRANCISCO CA 94133
Business Address
TOTH ROBERT JOSEPH JR (Reporting) CIK: 0001585020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 231233576